Fluids and Barriers of the CNS Establish Immune Privilege by Confining Immune Surveillance to a Two-walled Castle Moat Surrounding the CNS Castle

Overview

Journal Fluids Barriers CNS

Publisher Biomed Central

Date 2011 Feb 26

PMID 21349152

Citations 109

Authors

Britta Engelhardt

Caroline Coisne

Affiliations

Soon will be listed here.

Abstract

Neuronal activity within the central nervous system (CNS) strictly depends on homeostasis and therefore does not tolerate uncontrolled entry of blood components. It has been generally believed that under normal conditions, the endothelial blood-brain barrier (BBB) and the epithelial blood-cerebrospinal fluid barrier (BCSFB) prevent immune cell entry into the CNS. This view has recently changed when it was realized that activated T cells are able to breach the BBB and the BCSFB to perform immune surveillance of the CNS. Here we propose that the immune privilege of the CNS is established by the specific morphological architecture of its borders resembling that of a medieval castle. The BBB and the BCSFB serve as the outer walls of the castle, which can be breached by activated immune cells serving as messengers for outside dangers. Having crossed the BBB or the BCSFB they reach the castle moat, namely the cerebrospinal fluid (CSF)-drained leptomeningeal and perivascular spaces of the CNS. Next to the CNS parenchyma, the castle moat is bordered by a second wall, the glia limitans, composed of astrocytic foot processes and a parenchymal basement membrane. Inside the castle, that is the CNS parenchyma proper, the royal family of sensitive neurons resides with their servants, the glial cells. Within the CSF-drained castle moat, macrophages serve as guards collecting all the information from within the castle, which they can present to the immune-surveying T cells. If in their communication with the castle moat macrophages, T cells recognize their specific antigen and see that the royal family is in danger, they will become activated and by opening doors in the outer wall of the castle allow the entry of additional immune cells into the castle moat. From there, immune cells may breach the inner castle wall with the aim to defend the castle inhabitants by eliminating the invading enemy. If the immune response by unknown mechanisms turns against self, that is the castle inhabitants, this may allow for continuous entry of immune cells into the castle and lead to the death of the castle inhabitants, and finally members of the royal family, the neurons. This review will summarize the molecular traffic signals known to allow immune cells to breach the outer and inner walls of the CNS castle moat and will highlight the importance of the CSF-drained castle moat in maintaining immune surveillance and in mounting immune responses in the CNS.

Citing Articles

IQGAP2 regulates blood-brain barrier immune dynamics.

Katdare K, Kjar A, OBrown N, Neal E, Sorets A, Shostak A iScience. 2025; 28(3):111994.

PMID: 40071147 PMC: 11894336. DOI: 10.1016/j.isci.2025.111994.

Skull bone marrow and skull meninges channels: redefining the landscape of central nervous system immune surveillance.

Liu L, Zhang X, Chai Y, Zhang J, Deng Q, Chen X Cell Death Dis. 2025; 16(1):53.

PMID: 39875352 PMC: 11775313. DOI: 10.1038/s41419-025-07336-2.

Changes in Cx43 and AQP4 Proteins, and the Capture of 3 kDa Dextran in Subpial Astrocytes of the Rat Medial Prefrontal Cortex after Both Sham Surgery and Sciatic Nerve Injury.

Bretova K, Svobodova V, Dubovy P Int J Mol Sci. 2024; 25(20).

PMID: 39456773 PMC: 11507206. DOI: 10.3390/ijms252010989.

Postnatal Allergic Inhalation Induces Glial Inflammation in the Olfactory Bulb and Leads to Autism-Like Traits in Mice.

Tanaka E, Yamasaki R, Saitoh B, Abdelhadi A, Nagata S, Yoshidomi S Int J Mol Sci. 2024; 25(19).

PMID: 39408806 PMC: 11476352. DOI: 10.3390/ijms251910464.

Astrocytic DLL4-NOTCH1 signaling pathway promotes neuroinflammation via the IL-6-STAT3 axis.

Mora P, Laisne M, Bourguignon C, Rouault P, Jaspard-Vinassa B, Maitre M J Neuroinflammation. 2024; 21(1):258.

PMID: 39390606 PMC: 11468415. DOI: 10.1186/s12974-024-03246-w.

References

Mayadas T, Johnson R, Rayburn H, Hynes R, Wagner D . Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell. 1993; 74(3):541-54. DOI: 10.1016/0092-8674(93)80055-j. View

Pardridge W . Blood-brain barrier delivery. Drug Discov Today. 2007; 12(1-2):54-61. DOI: 10.1016/j.drudis.2006.10.013. View

Raine C, Cannella B, Duijvestijn A, Cross A . Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Lab Invest. 1990; 63(4):476-89. View

Kent S, Karlik S, Cannon C, Hines D, Yednock T, Fritz L . A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J Neuroimmunol. 1995; 58(1):1-10. DOI: 10.1016/0165-5728(94)00165-k. View

Bauer M, Brakebusch C, Coisne C, Sixt M, Wekerle H, Engelhardt B . Beta1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity. Proc Natl Acad Sci U S A. 2009; 106(6):1920-5. PMC: 2644139. DOI: 10.1073/pnas.0808909106. View

Bill R, Doring A, Deutsch U, Engelhardt B . PSGL-1 is dispensible for the development of active experimental autoimmune encephalomyelitis in SJL/J mice. J Neuroimmunol. 2010; 232(1-2):207-8. DOI: 10.1016/j.jneuroim.2010.10.008. View

Vajkoczy P, Laschinger M, Engelhardt B . Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J Clin Invest. 2001; 108(4):557-65. PMC: 209399. DOI: 10.1172/JCI12440. View

Steffen B, Breier G, Butcher E, Schulz M, Engelhardt B . ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am J Pathol. 1996; 148(6):1819-38. PMC: 1861637. View

Steffen B, Butcher E, Engelhardt B . Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am J Pathol. 1994; 145(1):189-201. PMC: 1887301. View

10.

Laschinger M, Vajkoczy P, Engelhardt B . Encephalitogenic T cells use LFA-1 for transendothelial migration but not during capture and initial adhesion strengthening in healthy spinal cord microvessels in vivo. Eur J Immunol. 2003; 32(12):3598-606. DOI: 10.1002/1521-4141(200212)32:12<3598::AID-IMMU3598>3.0.CO;2-6. View

11.

Alt C, Laschinger M, Engelhardt B . Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune.... Eur J Immunol. 2002; 32(8):2133-44. DOI: 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W. View

12.

Krumbholz M, Theil D, Steinmeyer F, Cepok S, Hemmer B, Hofbauer M . CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions. J Neuroimmunol. 2007; 190(1-2):72-9. DOI: 10.1016/j.jneuroim.2007.07.024. View

13.

Abbott N, Patabendige A, Dolman D, Yusof S, Begley D . Structure and function of the blood-brain barrier. Neurobiol Dis. 2009; 37(1):13-25. DOI: 10.1016/j.nbd.2009.07.030. View

14.

Medawar P . Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol. 1948; 29(1):58-69. PMC: 2073079. View

15.

Krueger M, Bechmann I . CNS pericytes: concepts, misconceptions, and a way out. Glia. 2009; 58(1):1-10. DOI: 10.1002/glia.20898. View

16.

Barker C, Billingham R . Immunologically privileged sites. Adv Immunol. 1977; 25:1-54. View

17.

Kerfoot S, Norman M, Lapointe B, Bonder C, Zbytnuik L, Kubes P . Reevaluation of P-selectin and alpha 4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis. J Immunol. 2006; 176(10):6225-34. DOI: 10.4049/jimmunol.176.10.6225. View

18.

Ransohoff R, Tani M, Glabinski A, Chernosky A, Krivacic K, Peterson J . Chemokines and chemokine receptors in model neurological pathologies: molecular and immunocytochemical approaches. Methods Enzymol. 1997; 287:319-48. DOI: 10.1016/s0076-6879(97)87023-1. View

19.

Cannella B, Raine C . The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol. 1995; 37(4):424-35. DOI: 10.1002/ana.410370404. View

20.

Doring A, Wild M, Vestweber D, Deutsch U, Engelhardt B . E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice. J Immunol. 2007; 179(12):8470-9. DOI: 10.4049/jimmunol.179.12.8470. View